These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29857523)

  • 61. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
    Ishrat T; Pillai B; Ergul A; Hafez S; Fagan SC
    Neurochem Res; 2013 Dec; 38(12):2668-77. PubMed ID: 24194350
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats.
    Zhao LR; Berra HH; Duan WM; Singhal S; Mehta J; Apkarian AV; Kessler JA
    Stroke; 2007 Oct; 38(10):2804-11. PubMed ID: 17761920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
    Ringelstein EB; Thijs V; Norrving B; Chamorro A; Aichner F; Grond M; Saver J; Laage R; Schneider A; Rathgeb F; Vogt G; Charissé G; Fiebach JB; Schwab S; Schäbitz WR; Kollmar R; Fisher M; Brozman M; Skoloudik D; Gruber F; Serena Leal J; Veltkamp R; Köhrmann M; Berrouschot J;
    Stroke; 2013 Oct; 44(10):2681-7. PubMed ID: 23963331
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
    Wang X; Tsuji K; Lee SR; Ning M; Furie KL; Buchan AM; Lo EH
    Stroke; 2004 Nov; 35(11 Suppl 1):2726-30. PubMed ID: 15459442
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.
    Pösel C; Scheibe J; Kranz A; Bothe V; Quente E; Fröhlich W; Lange F; Schäbitz WR; Minnerup J; Boltze J; Wagner DC
    Stroke; 2014 Aug; 45(8):2431-7. PubMed ID: 24984745
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
    Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
    Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke.
    Zhao LR; Piao CS; Murikinati SR; Gonzalez-Toledo ME
    Recent Pat CNS Drug Discov; 2013 Apr; 8(1):2-12. PubMed ID: 23173646
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angioedema and Hemorrhage After 4.5-Hour tPA (Tissue-Type Plasminogen Activator) Thrombolysis Ameliorated by T541 via Restoring Brain Microvascular Integrity.
    Chen QF; Liu YY; Pan CS; Fan JY; Yan L; Hu BH; Chang X; Li Q; Han JY
    Stroke; 2018 Sep; 49(9):2211-2219. PubMed ID: 30354988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Influence of granulocyte colony stimulating factor on distribution of bone marrow stem cells and its role in protecting brain in rats with cerebral ischemia].
    Li JS; Liu JX; Liu K; Wang DC; Ren WH; Zhang XF; Tian YS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jun; 23(6):333-6. PubMed ID: 21672379
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
    Asahi M; Rammohan R; Sumii T; Wang X; Pauw RJ; Weissig V; Torchilin VP; Lo EH
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.
    Zhu H; Fan X; Yu Z; Liu J; Murata Y; Lu J; Zhao S; Hajjar KA; Lo EH; Wang X
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1137-46. PubMed ID: 20068577
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
    Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
    Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke.
    Kanazawa M; Takahashi T; Nishizawa M; Shimohata T
    J Atheroscler Thromb; 2017 Mar; 24(3):240-253. PubMed ID: 27980241
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tissue-type plasminogen activator improves neurological functions in a rat model of thromboembolic stroke.
    Sakurama T; Kitamura R; Kaneko M
    Stroke; 1994 Feb; 25(2):451-6. PubMed ID: 8303756
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IM-12 activates the Wnt-β-catenin signaling pathway and attenuates rtPA-induced hemorrhagic transformation in rats after acute ischemic stroke.
    Wang T; Duan YM; Fu Q; Liu T; Yu JC; Sui ZY; Huang L; Wen GQ
    Biochem Cell Biol; 2019 Dec; 97(6):702-708. PubMed ID: 31770017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.